Thyroid Nodule Clinical Trial
Official title:
Comparison of the Effect of Three Different Peak Airway Pressures on Determining Intraoperative Bleeding Points in Thyroidectomies
Patients undergoing thyroidectomy will be divided into three groups (30 cm H2O Group I, 40 cm
H2O Group II, 50 cmH2O Group III). At the end of the operation patients will be applied peak
airway pressure manually according to involved groups.The time until the first hemorrhage is
seen in each group or if not seen pressure will be applied for 30 seconds and then will be
ended.We will record the blood pressure, spO2, HR, the first ETCO2 after the procedure,
postoperative haemorrhage that required surgery, and postoperative hematomas during peak
airway pressure increase during the operation in all patients. The 1st hour blood pressure,
nausea-vomiting score and pain score (NRS) will be recorded in the postoperative recovery
unit.
The primary end point of the study is intraoperative bleeding detected, and the secondary end
point is postoperative bleeding.
Patients will be divided into three groups (https://www.randomizer.org/) by computer assisted
randomization method (30 cm H2O in Group I, 40 cm H2O in Group II, 50 cmH2O in Group III peak
pressure will be applied). The time until the first hemorrhage is seen in each group or if
not seen pressure will be applied for 30 seconds and then will be ended.
Patients will be taken to the operation table and standard monitorization will be performed
consisting of ECG, non-invasive blood pressure and peripheral O2 saturation from the back
region. Anesthesia was induced with 2 mg / kg propofol (propofol 1% Fresenius, Fresenius
Kabi, Germany), 2 mg / kg fentanyl (Talinat 0,5mg / 10ml, AND, Turkey), 0.6 mg / kg
rocuronium (Muscuro 50mg / 5ml, Kocak Farma , Turkey) will be provided after the patients
were intubated orally. General anesthesia treatment will be provided with 2% Sevoflurane in
40% oxygen-air mixture. All patients will be ventilated in pressure controlled mode;
respiratory frequency: 12 / min, FiO2: 40% (oxygen-air mixture), I/E:1/2, PEEP: 7 cmH2O
supplying end tidal CO2 value of 32-36 mmHg.
Calculating the ideal weight of the patient, isolated-S (Polifarma, Turkey)2ml/kg/h will be
infused. If the systolic arterial pressure (SAB) or heart rate (HR) increases by 20% compared
to baseline, IV 50 μg fentanyl will be administered. At the end of the operation, the
patient's airway peak pressure will be increased before hemostasis is provided by the same
surgeon (S.T.). Positive pressure on the Maquet Flow I device (Maquet Flow I-AGC, Rastatt,
USA) will be applied manually(30 cm H2O in Group I, 40 cm H2O in Group II patients and 50 cm
H2O in group III patients). The airway peak pressure increase will be maintained and recorded
until the surgeon sees the first bleeding point or if not seen for 30 seconds. For all three
groups this process will be repeated one more time.
After peak airway pressure is increased, the number of bleeding centers detected, how long
time did it take to detect and the size of the bleeding vessel (<2 mm or> 2 mm)will be
recorded. We will record the blood pressure, spO2, HR, the first ETCO2 after the procedure,
postoperative haemorrhage that required surgery, and postoperative hematomas during peak
airway pressure increase during the operation in all patients. The 1st hour blood pressure,
nausea-vomiting score and pain score (NRS) will be recorded in the postoperative recovery
unit.
The primary end point of the study is intraoperative bleeding detected, and w the secondary
end point is postoperative bleeding.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04614389 -
Utility of Contrast-Enhanced Sonography and Shear Wave Elastography
|
N/A | |
Recruiting |
NCT03295955 -
Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy
|
N/A | |
Completed |
NCT04647006 -
Comparison of TOETVA and Conventional Thyroidectomy
|
N/A | |
Not yet recruiting |
NCT06029946 -
B-mode Ultrasound, Sono-Elastography, and Diffusion-weighted Imaging MRI in Thyroid Nodules
|
||
Recruiting |
NCT05025046 -
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
|
||
Terminated |
NCT01320813 -
Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy
|
N/A | |
Completed |
NCT00877630 -
Minimal Invasiveness of Endoscopic Thyroidectomy
|
N/A | |
Completed |
NCT01964508 -
microRNA in Thyroid Cancer
|
||
Completed |
NCT06306599 -
Ultrasound Operator Influence on Diagnostics With AI for Thyroid Nodules - Clinial Trial
|
N/A | |
Recruiting |
NCT04730726 -
In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules
|
N/A | |
Not yet recruiting |
NCT03884140 -
Clinical Diagnostic Approach for Cases of Thyroid Nodules
|
||
Completed |
NCT04277455 -
Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules
|
N/A | |
Recruiting |
NCT02225509 -
Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology
|
N/A | |
Completed |
NCT00552253 -
Levothyroxine Treatment in Thyroid Benign Nodular Goiter
|
N/A | |
Not yet recruiting |
NCT03700762 -
Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.
|
||
Enrolling by invitation |
NCT01757834 -
Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules
|
N/A | |
Completed |
NCT01292044 -
The Role of Elastography in the Diagnosis of Thyroid Nodules
|
N/A | |
Completed |
NCT00858104 -
Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results
|
Phase 4 | |
Completed |
NCT00651625 -
Reciprocating Medical Devices - a Study of a New Safety Device
|
N/A | |
Completed |
NCT05132478 -
The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer
|
N/A |